# Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)

> **NCT06212427** · NA · RECRUITING · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 188 (estimated)

## Conditions studied

- Premature Infant
- Low Birthweight Infant

## Interventions

- **DIETARY_SUPPLEMENT:** HMO supplement

## Key facts

- **NCT ID:** NCT06212427
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-20
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06212427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06212427, "Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06212427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*